Skip to main content
. 2020 Jul 5;4(8):bvaa091. doi: 10.1210/jendso/bvaa091

Figure 2.

Figure 2.

Poor linear growth illustrated by patient’s height tracking along the fifth percentile despite midparental height (MPH) being at the 50th percentile. Catch-up growth is evident after the patient was switched from dispersed hydrocortisone tablets to the pharmacy-compounded alcohol-free suspension. A peak of weight gain was also observed prior to presentation. Arrows represent time of switching to pharmacy-compounded suspension.